Skip to main content
NIH funding notice RFA-DK-19-020

Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed)

Closed on June 26, 2020.

Posted
November 6, 2019
Close date
June 26, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
2
2 new
Median first-year cost
$1,191,870
$2,383,739 in all
Institutions
2
2 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. COLUMBIA UNIVERSITY HEALTH SCIENCES1
  2. UNIVERSITY OF ALABAMA AT BIRMINGHAM1

Most frequent study sections

  1. Special Emphasis Panel (ZDK1 GRB-J (O1))2
2 awards under RFA-DK-19-020 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2020Enhancer-based Immune and Beta Cell Dysregulation Underlying T1D Risk1R01DK127778-01Egli, Dieter MeinradRosenfeld, Michael GSuh, YousinYu, HaiyuanCOLUMBIA UNIVERSITY HEALTH SCIENCES, NYFirst-year cost $1,193,316Study section ZDK1
FY2020Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes1R01DK127497-01Mathews, Clayton EMillman, Jeffrey RobertTse, Hubert MUNIVERSITY OF ALABAMA AT BIRMINGHAM, ALFirst-year cost $1,190,423Study section ZDK1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-DK-19-020: Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed) | ScienceDex | ConductScience